Export

EN
FR
ATC codes: L01BB03
EMLc
Indication
Lymphoid leukaemia, not elsewhere classified ICD11 code: 2C03.3
INN
Tioguanine
Medicine type
Chemical agent
List type
Complementary (EML)
(EMLc)
Formulations
Oral > Solid: 40 mg (EMLc)
EML status history
First added in 2011 (TRS 965)
Changed in 2015 (TRS 994)
Sex
All
Age
Children (1 month - 12 years)
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for tioguanine on the complementary list of the EMLc for use in treatment protocols for acute lymphoblastic leukaemia was specifically endorsed. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for acute lymphoblastic leukaemia is attached.